Biotech

All Articles

Former Seagen CEO reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2014 for a who...

Ironwood creates more bid for $1B GI medication along with brand-new subgroup data

.On the heels of a phase 3 gain that stopped working to make an impression on real estate investors,...

Novartis inks $150M offer for autoimmune molecular glue

.Don't stop Monte Rosa Rehabs right now. The Boston-based biotech is actually having a ball after si...

Jade carves out officer staff along with Chinook veterinarians-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ...

Septerna goes public along with upsized offering of $288M

.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...

AbbVie makes Richter wealthier, paying for $25M to make up invention deal

.AbbVie has come back to the source of its own antipsychotic giant Vraylar seeking an additional run...

GenSight enters into ultimate full weeks of cash runway as earnings flow noses out of grasp

.GenSight Biologics is full weeks far from running out of cash. Once more. The biotech merely has en...

AZ licenses thrown out uncommon condition medicine to Monopar Therapies

.Monopar Rehabs is actually recouping a medicine from the dump of AstraZeneca's unusual ailment pipe...

Arcus' new HIF-2a information in renal cancer mean prospective advantage over Merck's Welireg, professionals mention

.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...

Roche bets up to $1B to expand Dyno gene treatment delivery contract

.After creating a gene therapy relationship with Dyno Rehabs in 2020, Roche is back for additional.I...